MPPF, with the full name 2'-methoxyphenyl-(N-2'-pyridinyl)-p-fluoro-benzamidoethyipiperazine, is a compound that binds to the serotonin-1A receptor. Labeled with fluorine-18 it has been used as a radioligand with positron emission tomography. It has, e.g., been used to examine the difference in neuroreceptor binding in the human brain across sex and age.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|
- ↑ D. Le Bars (May 1998). [Expression error: Missing operand for > "High-Yield Radiosynthesis and Preliminary In Vivo Evaluation of p-18FMPPF, a Fluoro Analog of WAY-100635"]. Nuclear Medicine and Biology 25 (4): 343–350. doi:10.1016/S0969-8051(97)00229-1.
- ↑ Nicolas Costes; Merlet, I; Ostrowsky, K; Faillenot, I; Lavenne, F; Zimmer, L; Ryvlin, P; Le Bars, D (December 2005). [Expression error: Missing operand for > "A18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging"]. the Journal of Nuclear Medicine 46 (12): 1980–1989. PMID 16330560.